Dicerna Pharmaceuticals, Inc. — Operating Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/88a438bd-bf19-46f6-bfee-b562bf0af9b0/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2020 | $-113.2M | 2020-01-01 – 2020-12-31 | evidence 0001399529-21-000042 |
| FY 2019 | $-128.2M | 2019-01-01 – 2019-12-31 | evidence 0001399529-20-000009 |
| FY 2018 | $-90.4M | 2018-01-01 – 2018-12-31 | evidence 0001399529-19-000005 |
| FY 2017 | $-60.7M | 2017-01-01 – 2017-12-31 | evidence 0001399529-19-000005 |
| FY 2016 | $-59.7M | 2016-01-01 – 2016-12-31 | evidence 0001193125-17-104169 |
| FY 2015 | $-63.0M | 2015-01-01 – 2015-12-31 | evidence 0001193125-16-500111 |
| FY 2014 | $-45.1M | 2014-01-01 – 2014-12-31 | evidence 0001193125-16-500111 |
| FY 2013 | $-17.4M | 2013-01-01 – 2013-12-31 | evidence 0001193125-16-500111 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Dicerna Pharmaceuticals, Inc. — all facts · Revenue · Net Income